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Abstract 
The presecretory protein ppcecDHFR, a hybrid between preprocecropinA and dihydrofolate reductase, istransported into mammalian microsomes 
post-translationally, i.e. independent of ribosome and signal recognition particle. Here, the involvement of microsomal proteins in ribonucleoparticle- 
independent ransport of ppcecDHFR was analyzed by transport into trypsin-pretreated microsomes and by transport of a truncated version of 
ppcecDHFR and subsequent chemical cross-linking. We observed that post-translational transport of ppcecDHFR can occur into microsomes which 
had been pretreated with trypsin @ml concentration, 100 @nl) and that of the known transport components only TRAMP and se&lap are still 
present under these conditions. Furthermore, we found that the truncated ppcecDHFR, ppcecDHFR-98mer’, can be cross-linked to 36 kDa 
microsomal membrane proteins during post-translational transport. Therefore, the two microsomal membrane proteins with molecular masses of 
about 36 kDa, TRAMP and sec6lap, appear to be involved in the post-translational transport of ppcecDHFR and ppcecDHFR-98mer. 
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1. Introdnctlon 
The initial step in the biogenesis of most eukaryotic 
secretory proteins is their transport into the lumen of the 
endoplasmic reticulum [l-3]. Membrane transport of 
presecretory proteins can be divided into the following 
stages: (i) specific association of the proteins with the 
membrane, (ii) membrane insertion, and (iii) complete 
transfer across the membrane. During the first stage, 
specificity is facilitated by a characteristic amino-termi- 
nal signal peptide in the precursor proteins and by solu- 
ble and/or membrane-bound signal peptide binding pro- 
teins. The second and third stage are mediated by a 
translocase in the microsomal membrane which com- 
prises proteins TRAMP (mp39), sec61&p (P37, imp34), 
sec61jIp and sec6lyp [4-121. 
There are two classes of precursor proteins with re- 
spect to their mechanism of transport into mammalian 
microsomes [2]. Transport of precursor proteins with 
more than 70 amino acid residues depends on two ribo- 
nucleoparticles, the ribosome and the signal recognition 
particle (SRP), as well as on their receptors on the micro- 
somal surface (ribosome- and SRP receptor, respec- 
tively) and involves the hydrolysis of GTP. The other 
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class typically consists of precursor proteins with less 
than 70 amino acid residues and is transported independ- 
ently of the ribonucleoparticles and their receptors. In- 
stead, a cytosolic molecular chaperone, i.e. Hsc70, and 
the hydrolysis of ATP are required [13-151. Both, ribo- 
nucleoparticle-dependent as well as -independent precur- 
sor proteins are inserted into the membrane under partic- 
ipation of microsomal proteins which are sensitive to 
N-ethyhnaleimide (NEM) treatment [11,16,17] and to 
photoaffinity labeling with azido-ATP [ 18-291, respec- 
tively. This suggests that the two mechanisms converge 
at the level of membrane insertion. 
We have studied the transport of a synthetic precursor 
protein (PpcecDHFR, 252 amino acid residues), a hybrid 
between the presecretory protein preprocecropinA 
(PpcecA, 64 amino acid residues) and the cytosolic pro- 
tein dihydrofolate reductase (DHFR), into dog pancreas 
microsomes [21,22]. Transport of this precursor could 
proceed under post-translational conditions, i.e. inde- 
pendently of ribosome, SRP, and the a-subunit of SRP 
receptor (docking protein), and was signal peptide- and 
ATP-dependent. 
Here, the involvement of microsomal proteins in ribo- 
nucleoparticle-independent transport of ppcecDHFR 
was further analyzed by transport into trypsin-pre- 
treated microsomes and by transport of a truncated ver- 
sion of ppcecDHFR (ppcecDHFR-98mer) and subse- 
quent chemical cross-linking. 
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translational transport of ppcecDHFR into dog pan- 
creas microsomes [21]. In order to gain further insight 
into which microsomal components are involved in the 
transport of ppcecDHFR under these conditions, micro- 
somes were pretreated with increasing concentrations of 
trypsin and analyzed with respect to their content of 
certain microsomal membrane proteins as well as with 
respect o their transport activity (Table 1). 
After synthesis in reticulocyte lysate, transport of 
ppcecDHFR occurred with a higher than 50% efficiency 
(i.e. as compared to untreated microsomes) even after 
pretreatment of microsomes with trypsin at a final con- 
centration of 100 ,@ml and subsequent inhibition of 
trypsin. The 23 kDa-subunit of signal peptidase as well 
as the signal peptidase activity were more or less unaf- 
fected by this treatment, indicating that the microsomes 
were almost intact. It can be concluded that, under the 
experimental conditions used, the a- and/&subunit of the 
SRP receptor [23] and the putative ribosome receptor 
ERpl80 [24] are not necessary for transport of 
ppcecDHFR. These observations are of particular rele- 
vance since these three proteins were described to have 
an afhnity for nucleoside triphosphates [ 19,251. Further- 
2. Materials and methods 
2.1. Materials 
[35S]Methionine (1,000 Ci/mmol) and ECL Western blotting reagent 
were obtained from Amersham. EcoRI, PvuII, ScaI, RNase A, pro- 
teinase K, SP6 polymerase and ATP were purchased from Boehringer 
Mannheim. Cycloheximide, potato apyrase (grade VIII), puromycin 
and the non-hydrolyzable GTP-analog were obtained from Sigma. X- 
ray films (X-Omat AR) were from Kodak. The homobifunctional 
cross-linking reagent, dithiobis(succinimidylpropionate) (DSP), and 
the heterobifimctional cross-linking reagent, succinimidyl 4-(N- 
maleimidomethyl)cyclohexane-I-carboxylate (SMCC), were obtained 
from Pierce Chemical Co. Phenyhnethylsulphonyl fluoride was pur- 
chased from Merck. 
2.2. In vitro translation and transport 
Dog pancreas microsomes were isolated and treated with micrococ- 
cal nuclease and EDTA as described [21]. Treatment of microsomes 
with trypsin, NEM (final concentration 4 mM) and mock-treatment, 
respectively, were carried out according to published procedures 
[17,21]. 
Plasmid pCA2 containing the ppcecDHFR coding region down- 
stream of the SP6 promoter was linearized with EcoRI and transcribed 
with SP6 polymerase [21]. Translation in rabbit reticulocyte lysate in 
the presence of in vitro transcript and [35S]methionine (tinal concentra- 
tion 1.4 mCi/ml) and post-translational transport were carried out as 
described previously [21]. For post-translational transport of truncated 
ppcecDHFR, plasmid pCA2 was linearized with ScuI and transcribed 
with SP6 polymerase. The transcript which coded for the 98 amino- 
terminal amino acid residues of ppcecDHFR and lacked a termination 
codon was used to program a reticulocyte lysate. After translation for 
20 min at 3O”C, puromycin (final concentration 1.25 mM) was added 
and the incubation was continued for 5 min. Then, dog pancreas micro- 
somes were added and a subsequent incubation was carried out for 
10 min at 30°C. 
Plasmid pB4 which contains the preprolactin (ppl) coding for the 
region downstream of the SP6 promoter was linearized with PvuII and 
transcribed with SP6 polymerase as described [17. The transcript which 
coded for the 86 amino-terminal amino acid residues of ppl and lacked 
a termination codon was used to program a reticulocyte lysate. 
2.3. Chemical cross-linking 
Cross-linking was carried out after re-isolation of microsomes with 
either dithiobis DSP or SMCC as cross-linking reagents. Typically, 
transport reactions were diluted with an equal volume of XL-buffer 
(50 mM HEPES-KOH, pH 7.5, 50 mM K-acetate, 2 mM Mg-acetate, 
200 mM sucrose) and microsomes were subsequently re-isolated by 
centrifugation (125.000 x g for 10 min at 2°C). The microsomal pellet 
was resuspended in 25 ~1 of XLbuffer and supplemented with 0.25 ,~l 
of the cross-linking stock solution (5 mg/ml DMSO). Cross-linking was 
carried out for 20 min at 0°C and terminated by the addition of SDS- 
sample buffer. 
2.4. Analytical procedures 
Sequestration assays were performed for 60 min at 0°C in 80 mM 
sucrose and proteinase K (50 pg/ml). The controls received water in- 
stead of protease. Proteolysis was stopped by addition of phenylmeth- 
ylsulphonyl fluoride (10 mM) and further incubation for 5 min at 0°C. 
Samples were subjected to electrophoresis n high Tris/urea/SDS-poly- 
acrylamide gels (SDS-PAGE) [21]. In the case of DSP-cross-linked 
samples, /3-mercaptoethanol was omitted from the SDS-sample buffer. 
The gels were treated with 1 M sodium salicylate, dried and exposed 
to X-ray films. Densitometric analysis was performed with a LKB 
Ultrascan XL laser densitometer. 
3. Results 
3.1. Transport of ppcecDHFR into trypsin-pretreated 
microsomes 
It has previously been shown that ribosome, SRP, and 
the a-subunit of SRP receptor are not involved in post- 
Table 1 
The role of microsomal proteins in the transport of ppcecDHFR under 
post-translational conditions 
Residual amount of intact protein and 
of activity, respectively (% of control) 
Trypsin @g/ml) 0.3 1.0 3.0 10 30 100 
SRP receptor a-subunit 80 5 0 0 0 0 
SRP receptor /?-subunit 89 80 47 29 0 0 
Ribosome receptor (ERpl80) n.d. 1 3 0 0 0 
TRAMP (mp39) 50 0 0 0 0 0 
sec6lp (P37) 98 116 100 81 64 24 
SPase 23 kDa-subunit 86 103 108 93 114 111 
SPase activity 90 85 81 65 n.d. 63 
Transport activity 92 118 130 94 89 58 
Dog pancreas microsomes were subjected to trypsin treatment at the 
indicated final concentrations of TPCK-trypsin as described previously 
[21]. The trypsin-pretreated microsomes were analyzed with respect o 
their content of SRP receptor a- and /?-subunit, ERpl80, TRAMP, 
sec6lap, and signal peptidase (SPase) 23 kDa subunit by Western 
blotting and decoration with specific antibodies and an appropriate 
second antibody-peroxidase conjugate. Detection of antibody was per- 
formed by coupled chemiluminescence (ECL) and quantified by laser 
densitometry of the X-ray films. Furthermore, these microsomes were 
characterized with respect to their abilities to process ppcecDHFR 
under different conditions: (i) signal peptidase assays were carried out 
in 0.25% Triton X-100 and quantified (SPase activity) as described [21]; 
(ii) translation of ppcecDHFR in the presence of [35S]methionine was 
carried out in the rabbit reticulocyte lysate for 15 min at 37’C. Trans- 
lation was terminated by addition of cycloheximide and RNase A. 
Aliquots were further incubated for 30 min at 37°C in the presence of 
various microsomes. Each reaction was divided into two halves and 
incubated further in the presence or absence of protease. The samples 
were analyzed by SDS-PAGE and fluorography. The efficiencies of 
processing and sequestration, respectively, were quantified by laser 
densitometry of the autoradiographs. The sequestration efficiencies are 
shown (transport activity). 
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Fig. 1. Transport of truncated ppcecDHFR, ppcecDHFR_98mer, into microsomes. Plasmid pCA2 was linearized within the coding region and 
transcribed with SP6 polymerase. After translation in rabbit reticulocyte lysate for 20 min at 30°C the translation mixture was divided into four 
aliquots. These aliquots were supplemented with water (lane l), microsomes (RMko) (lanes 2 and 3) or puromycin (final concentration 1.25 mM) 
(lane 4). Following a subsequent incubation of samples 24 for 5 min, puromycin or microsomes (RM/post) were added to samples 3 and 4, 
respectively, and the transport reaction was carried out for 5 (lane 3) or 10 min (lane 4) at 30°C. Then, all samples were divided into four aliqouts. 
One aliquot was incubated in the absence of protease (lanes 14), a second aliquot in the presence of protease (lanes 5-8), a third one in the presence 
of protease plus EDTA (final concentration 5 mM) to release the ribosomes from the membrane (lanes 9-12), and a fourth aliquot in the presence 
of protease plus Triton X-100 (final concentration 2.5%) (lanes 13-16). All samples were analyzed by SDS-PAGE [21] and fluorography. 
more, one could conclude from these data that intact 
TRAMP [4,6,12] is not essential for transport of 
ppcecDHFR. However, in this particular case only a 
small C-terminal cytosolic domain (recognized by the 
antibody, raised against a C-terminal peptide) may have 
been destroyed by trypsin and this domain is not re- 
quired for TRAMP function [4]. On the basis of its rela- 
tive protease-resistance, sec6lap [5,7-9,l l] may be in- 
volved in transport of ppcecDHFR. 
3.2. ATP-depletion or NEMpretreatment of microsomes 
inhibit association of ppcecDHFR-98mer with the 
microsomal membrane proteins, TRAMP and 
se&l up 
It has previously been shown that nascent chains (i.e. 
peptidyl-tRNAs) of ribonucleoparticle-dependent pre- 
cursor proteins which are in transit into mammalian mi- 
crosomes (such as a nascent preprolactin chain, termed 
ppL86mer) are in close contact with the microsomal 
membrane proteins TRAMP (which is glycosylated) and 
sec6 1 up (which is not glycosylated) [5-l 21. Therefore, we 
asked here whether this is true for ppcecDHFR in transit 
into the microsomal umen under post-translational con- 
ditions and at what stage ATP-depletion or NEM-pre- 
treatment of microsomes inhibit transport. 
For this purpose a nascent chain which is related to 
ppcecDHFR (ppcecDHFR-98mer) was generated in the 
reticulocyte lysate and subsequently released from ribo- 
somes, i.e. converted to the puromycin-containing deriv- 
ative OppcecDHFR-98mer’) either prior to or after addi- 
tion of microsomes (Fig. 1). When ppcecDHFR-98mer 
was incubated with microsomes in the absence of puro- 
mycin, a fraction of the ribosome-bound precursors was 
protected against protease by the ribosome, i.e. was pro- 
tease sensitive in the presence of EDTA (ppcecDHFR- 
98mer’ in lanes 6 and 10). It was chased to the processed 
and sequestered form by release from the ribosome 
(pcecDHFR-76mer’ in lanes 7 and 11). Another fraction 
of the ribosome-bound precursors was processed to 
pcecDHFR-76mer’ which was protease-sensitive in the 
presence of EDTA (lane 6 vs. 10). It was chased to the 
sequestered form by release from the ribosome (lanes 7 
vs. 11). Furthermore, there was processing and seques- 
tration when microsomes were added after release of the 
precursor form from the ribosome (Fig. 1, lanes 4, 8, 12, 
16). Transport under these ribosome-independent condi- 
tions (post-translational conditions) occurred even after 
pre-trypsinization of microsomes (data not shown), i.e. 
in the absence of docking protein (Table 1). When ppl- 
86mer was incubated with microsomes in the absence of 
puromycin, ribosome-bound precursor was protected 
against protease by the ribosome, i.e. protease-sensitive 
in the presence of EDTA, and was chased to the proc- 
essed and sequestered mature form by release from the 
ribosome (data not shown). However, there was no proc- 
essing and sequestration when microsomes were added 
after release of the precursor form from the ribosome, 
which demonstrated the quantitative ffect of puromycin 
(data not shown). Thus, in contrast to ppl-86mer and 
full-length ppl, ppcecDHFR-98mer can be transported 
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Fig. 2. Chemical cross-linking of ppcecDHFR-98mer to 36 kDa micro- 
somal membrane proteins. The truncated presecretory protein 
ppcecDHFR-98mer was synthesized in vitro as described in the legend 
to Fig. 1. After puromycin-treatment, microsomes were added and the 
mixture was divided into four aliquots on ice. The transport reaction 
was carried out for 0, 3,9, or 27 min at 30°C. Afterwards the samples 
were kept on ice. After re-isolation, the microsomes were incubated 
with the cleavable cross-linker DSP and subsequently subjected to SDS- 
PAGE and fluorography (A). The precursor and mature forms, cross- 
linked and non-cross-linked, were quantified by laser densitometry of 
the autoradiographs (the arbitrary units for the cross-linked forms have 
to be divided by ten in order to be compared irectly with the non-cross- 
linked forms) (B). We note that, simultaneously with processing of 
ppcecDHFR-98mer to pcecDHFR-76mer, a cross-linking product be- 
tween pcecDHFR-76mer’ and two soluble proteins in the microsomal 
lumen appeared (i.e. after re-isolation of the cross-linking product 
(which was termed pcecDHFR-76mer’ X 55 kDa (m X 55 in B)) from 
the gel and subsequent SDS-PAGE in the presence ofg-mercaptoetha- 
nol, pcecDHFR-76mer’ was detected). 
A 
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; : ; 
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into mammalian microsomes post-translationally, i.e. it 
behaves like full-length ppcecDHFR [21]. 
Under these post-translational transport conditions 
ppcecDHFR-98mer’ could be cross-linked to 36 kDa 
microsomal protein(s) (Fig. 2A). We note that (i) the 
appearance of the cross-linking product, termed 
ppcecDHFR-98mer’ X 36 kDa (p X 36 in Fig. 2B) on the 
basis of its co-migration with marker proteins, depended 
on the presence of transport-competent microsomes 
(Fig. 5) as well as on cross-linker (Figs. 3 and 5) and that 
(ii) ppcecDHFR-98mer’ was detected after re-isolation 
of the cross-linking product from the gel and subsequent 
SDS-PAGE in the presence of &mercaptoethanol. This 
cross-linking product was also observed under co-trans- 
lational transport conditions, such as described in Fig. 
1, lanes 2, 6, 10, 14 (data not shown). Under post-trans- 
lational conditions it was observed only transiently, i.e. 
it was detected shortly after addition of microsomes and 
disappeared with increasing incubation time, concomi- 
tant with the appearance of sequestered pcecDHFR- 
76mer’ (Fig. 2A and B). Thus, ppcecDHFR-98mer, 
bound to the microsomal 36 kDa proteins, represents a 
transport intermediate. The cross-linking product resem- 
bled that of ppL86mer (i.e. in the absence of puromycin, 
data not shown) in several respects: (i) it behaved as a 
membrane protein, i.e. it could not be extracted by alka- 
line treatment of the membrane (data not shown); (ii) it 
was partially retained on concanavalin A-agarose (data 
not shown), suggesting a glycoprotein; and (iii) it could 
be partially immunoprecipitated by antibodies which 
were directed against TRAMP and sec6 1 &p, respectively 
(data not shown). The cross-linking product of 
ppcecDHFR-98mer’ was visible both at 0°C (where 
transport did not occur) and at 30°C (where transport 
occurred) (Fig. 3, left panel). On the basis of these char- 
acteristics, the microsomal cross-linking partners of 
ppcecDHFR-98mer’ appear to be identical to the constit- 
- ppcecDHFR-98mer’ 
- pcecDHFR-76mer’ 
i 
m 151 
IO 20 
time (min) 
uents of the translocase, TRAMP (glycoprotein) and 
sec6lap (non-glycoprotein). 
Again, as in the case of cross-linking of ppL86mer 
(Fig. 4), the cross-linking product of ppcecDHFR- 
98mer’ was not detected after apyrase treatment (Fig. 3, 
left panel) or NEM-pretreatment of microsomes (Fig. 5), 
i.e. under non-transport conditions. However, the tar- 
gets of nucleoside triphosphate depletion have to be dif- 
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Fig. 3. Chemical cross-linking of ppcecDHFR-98mer to 36 kDa microsomal membrane proteins is prevented by apyrase pretreatment but not by 
addition of GMP-PNP. The truncated presecretory protein ppcecDHFR-98mer was synthesized in vitro and the translation mixture was divided into 
six aliqouts and supplemented with puromycin plus either water, or apyrase (final concentration 100 U/ml), or GMP-PNP (final concentration 
1.25 mM). Following incubation for 5 min, microsomes were added and the transport reaction was carried out for 10 min at 0 or 30°C as indicated. 
After re-isolation, the microsomes were incubated in the absence or presence of DSP and subsequently subjected to SDS-PAGE and fluorography. 
The lower part of the figure represents a short exposure (15 h) of the upper parts area of interest (150 h, left panel; 75 hrs, right panel). 
ferent for both presecretory proteins. In the case of ppl- 
86mer, the effects are obviously due to the inactivation 
of the GTP-dependent SRP receptor a-subunit. How- 
ever, as shown in Table 1, SRP receptor d-subunit is not 
involved in the transport of ppcecDHFR-98mer’. This 
view is further substantiated by the experiments in which 
the non-hydrolyzable GTP-analog guanosine S-(,&y- 
imido)-triphosphate (GMP-PNP) was employed. In the 
case of ppl-86mer, as expected [26], (i) a reduction of 
transport, (ii) a decrease in the extent of cross-linking to 
the 36 kDa proteins, and (iii) a concomitant appearance 
of a cross-linking product between ppL86mer and the 54 
kDa subunit of SRP were observed (Fig. 4). However, 
in the case of ppcecDHFR-98mer’ none of these effects 
were observed (Fig. 3, right panel). On the other hand, 
the targets of NEM treatment of microsomes may be 
identical for ppL86mer and ppcecDHFR-98mer’ [ 111. 
With respect to the ATP requirement, we cannot distin- 
guish between two possibilities: either ATP is used by the 
microsomal protein which is sensitive towards azido- 
ATP photoaffinity modification, or it is used by this 
microsomal protein and Hsc70 which may be associated 
with ppcecDHFR-98mer’. 
4. Discussion 
The results obtained can be interpreted as follows. 
Since post-translational transport of ppcecDHFR can 
occur into trypsin-pretreated microsomes (final concen- 
tration 100 &ml) we conclude that of the known trans- 
port components only TRAMP and sec61&p appear to 
be candidates which could be involved in transport of 
ppcecDHFR. From the fact that truncated ppcecDHFR, 
ppcecDHFR-98mer’, can be cross-linked to 36 kDa mi- 
crosomal membrane proteins during post-translational 
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ppl-86mer 
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Fig. 4. Chemical cross-linking of ppl-86mer to 36 kDa microsomal membrane proteins is prevented by apyrase pretreatment and by addition of 
GMP-PNP. The truncated presecretory protein ppl-86mer was synthesized in vitro (see section 2) and the translation mixture was divided into four 
aliqouts and supplemented with water, apyrase (final concentration 100 U/ml) and GMP-PNP (final concentration 1.25 mM), respectively, as 
indicated. Following incubation for 5 min, microsomes were added and the targeting reaction was carried out for 5 min at 30°C. Each targeting 
reaction was divided into two aliqouts, supplemented with water or puromycin as indicated, and the transport reaction was carried out for 5 min 
at 30°C. After re-isolation, the microsomes were incubated in the presence of SMCC and subsequently subjected to SDS-PAGE and fluorography. 
We note that simultaneously with processing of ppl-86mer to pl-56mer, a cross-linking product between pl-56mer and two soluble proteins in the 
microsomal umen appeared (lane 5; Klappa and Zimmermann, manuscript in preparation). 
transport, one can conclude that transport of 
ppcecDHFR-98mer may actually involve both micro- 
somal membrane proteins with molecular masses of 
about 36 kDa, i.e. TRAMP and sec6lap. Since the post- 
translational transport of both, ppcecDHFR and 
ppcecDHFR-98mer’ (i) occurs after release from the ri- 
bosome, (ii) does not involve the GTP-dependent SRP/ 
SRP receptor system, (iii) is inhibited by ATP-depletion, 
and (iv) is inhibited by NEM-pretreatment of micro- 
somes, it seems clear that the full-length precursor and 
its truncated derivative are transported in a similar or 
even identical fashion. 
In summary, we conclude that post-translational 
transport of ppcecDHFR occurs via the translocase 
which is involved in ribonucleoparticle-dependent trans- 
port, and that a microsomal protein which is sensitive 
towards treatment with N-ethylmaleimide is involved in 
mediating association of the presecretory protein in tran- 
sit with the components of translocase, i.e. TRAMP and 
sec61ccp. A similar NEM sensitivity had been reported 
for preprolactin [l 11. Furthermore, one can conclude 
that a cytosolic and/or microsomal protein which de- 
pend(s) on ATP is involved in mediating association of 
ppcecDHFR in transit with components of the translo- 
case. Again, a similar conclusion was reached previously 
for preprolactin after photoaffinity modification of mi- 
crosomes with azido-ATP [20]. Furthermore, this situa- 
tion is very similar to what has been observed for post- 
translational transport of proteins into yeast microsomes 
[27,28]. 
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